Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/8083713

Download in:

View as

General Info

PMID
8083713